DOCSLIB.ORG

It's What's Inside That Counts

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

It’s What’s Inside That Counts HIGH-QUALITY NUTRITIONAL SUPPLEMENTS YOU CAN TRUST WHY PURE ENCAPSULATIONS® We offer the most comprehensive GOODNESS ENCAPSULATED DRIVEN BY SCIENCE At Pure Encapsulations®, we know it’s what’s inside Pure Encapsulations® is driven by science, and line of supplements that counts. We’ve spent 30 years researching, the proof is in our products. Every supplement is FREE FROM: ** innovating, and developing our comprehensive line made using only premium ingredients sourced from of premium supplements, made with high-quality, trusted suppliers around the world and guided pure ingredients, backed by verifiable science to by our team of scientific and medical experts. So complement your plan of care. Everything you patients can feel as confident about what they put need and nothing you don’t— that’s goodness into their bodies as you are recommending it. encapsulated. Wheat, Soy*, Tree Nuts Gluten Dairy*, Eggs & Peanuts THE PURE DIFFERENCE WHAT YOU SEE We take high standards seriously, which is why IS WHAT YOU GET we’re the most recommended professional We know it’s what’s on the inside that counts, supplement brand, ranked highest in quality and it shows right on our labels. Every ingredient 1 Artificial Colors, Coatings GMOs† and trust. What makes us different is the promise we put into our products, even if it’s just a trace Flavors & & Shellacs Sweeteners of goodness that goes into every one of our amount, is listed on the label. And if there’s an supplements. Our supplements are made with ingredient sourced from a possible allergen— only premium ingredients sourced from trusted we call that out too. We also list minerals by suppliers and guided by our nutritional experts, their true elemental weight and standardizations then carefully manufactured and tested to ensure of herbal extracts. Unnecessary Magnesium Trans Fat & they are FREE FROM unnecessary additives and Binders, Fillers Stearate Hydrogenated Oils & Preservatives many common allergens. 1. Among brands surveyed, Nutrition Business Journal® 2016, 2020; Kaiser Associates 2014 2. Among professional supplement brands surveyed, Nutrition Business Journal® 2016, 2020 †Visit PureEncapsulations.com for more information on our GMO policy. *Except where labeled. **As of 10/22/2019 among leading professional brands. 2 Ask your pharmacist about Pure Encapsulations today or visit PureEncapsulations.com for more information. ‡These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. 3 GOOD FROM START TO FINISH QUALITY PROMISE Our products don’t go to market without meeting the most stringent criteria to ensure the highest quality. We ensure the integrity of every product with the promise of premium sourced ingredients, verifiable science, and significant testing by certified independent laboratories of our raw materials and final products, to verify their potency and purity. All of our raw materials are tested for identity, potency, microbial contaminants, heavy metals (including mercury, arsenic, cadmium and lead), 32 solvent residues, and allergens, depending on risk. Herbal ingredients are tested for 70 different pesticide compounds, and essential fatty acids and fish/krill oils are tested for dioxins, furans, PCBs, and other agents. We also have a comprehensive Allergen SOP (Standard Operating Procedure) that prevents ingredient cross-contamination by flagging allergen-containing ingredients. So you can feel confident knowing only the best of the best ever make it into your hands. Pure Encapsulations is NSF-GMP registered in the U.S., GMP certified in Canada and exceeds the standards of the United States Pharmacopeia (USP) for supplement manufacturing. 4 ‡ 5 Ask your pharmacist about Pure Encapsulations today or visit PureEncapsulations.com for more information. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. STRONG CONNECTIONS Our strength lies in our partnerships with leaders in the most important nutritional health areas: genomics, mental health and emotional well-being, weight management, immunology, gastrointestinal health, and more. We partner with medical experts who not only help us formulate products, but also help to develop clinical protocols based on their success with our products, which they test and validate through clinical practice while advancing our ongoing education initiatives. PURE VALUES At Pure Encapsulations®, we don't just focus on making something good, but doing good as well. That's why we're proud to support non-profit organizations that are dedicated to supporting global wellness, improving the health of those most in need, and enriching lives around the world. Furthermore, we are committed to creating a more sustainable future for our planet. EVIDENCE-BASED NUTRITION Pure Encapsulations® is a leader in nutritional science with a long-standing commitment to scientific innovation. To date, we have more than 50 product-specific clinical studies published in leading peer-reviewed journals. Our investment in clinical research aims not only to promote product safety, efficacy, and innovation, but to elevate the status of nutrition science in general. These efforts have yielded key findings and resulted in a continuous output of publications in top scientific journals. 6 ‡These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. 7 ™ Manganese (as manganese citrate) 2 mg ™ O.N.E. Multivitamin Chromium (as chromium polynicotinate) 200 mcg O.N.E. Multivitamin Comparison ® With Metafolin® L-5-MTHF Molybdenum (as TRAACS molybdenum glycinate chelate) 75 mcg Boron (as boron glycinate) 1 mg ONCE-DAILY NUTRIENT ESSENTIALS WITH Inositol 25 mg SUSTAINED-RELEASE COQ10 ™ ® CoenzymeQ10 (as CoQ10 and as 18% from MicroActive 50 mg Leading Brand O.N.E. Multivitamin Indications: CoQ10-cyclodextrin complex Preservatives Sodium benzoate, sorbic acid, BHT None • Men and women age 18 and over Alpha lipoic acid 50 mg FloraGLO® lutein 3 mg Vitamin Distinctions: Zeaxanthin 500 mcg Colors Artificial red, yellow & blue aluminum lake None • Provides vitamins A, B, C, D and E in highly bioavailable forms Lycopene 500 mcg ® • Includes Metafolin L-5-methyltetrahydrofolate (L-5-MTHF), the Other ingredients: vegetarian capsule (cellulose, water), hypoallergenic naturally occurring, universally metabolized form of folate plant fiber (cellulose), ascorbyl palmitate, potato starch Sweeteners Sucrose None Special Features: Metafolin® is a registered trademark of Merck KGaA, Darmstadt, Germany. • Convenient one-capsule-per-day dosing Hydrogenated Oils Yes (palm oil) None ® • Antioxidant complex includes alpha lipoic acid and a blend of FloraGLO is a registered trademark of Kemin Industries, Inc. ® CoQ and sustained-release water-soluble MicroActive Q ® ® 10 10 Zeaxanthin is sourced from OPTISHARP brand. OPTISHARP ‡ Animal Products Yes (gelatin) Vegetarian • Choline and inositol for healthy cognitive function is a trademark of DSM. • Supports cellular health with 500 mcg lycopene and 50 mcg TRAACS® is a registered trademark of Albion Laboratories, Inc. (2,000 IU) vitamin D‡ Allergens None None ® ® • Helps maintain macular and retinal health with 3 mg lutein and ChromeMate brand niacin-bound chromium. ChromeMate & logo 500 mcg zeaxanthin‡ are trademarks of Lonza or its affiliates. ® Acacia gum, calcium stearate, crospovidone, 1 capsule daily, with a meal. MicroActive is a registered trademark of BioActives, LLC. Excipients hypromellose, polyethylene glycol, polyvinyl alcohol, Potato starch Each (size 00) vegetarian capsule contains: talc, titanium dioxide Multivitamins, Vitamins & Minerals Vitamin A (as vitamin A acetate and 73% beta carotene) 1,125 mcg Vitamin C (as ascorbic acid) 180 mg O.N.E.™ Multivitamin Quantity Order Code Range from 100-250%+ DV; includes activated B Vitamin D (as cholecalciferol) (D3) 50 mcg (2,000 IU) Generally 100% DV; does not contain activated 60 ONE6 Vitamins vitamins: Metafolin®, methylcobalamin, riboflavin 5’ vitamins Vitamin E (as d-alpha tocopherol succinate) 20 mg 30 ONE3 phosphate, pyridoxal 5’ phosphate Thiamin (as thiamin HCl) (B1) 3 mg Riboflavin (as vitamin B2 and 43% riboflavin 5' phosphate 3 mg Carbonate, phosphate, chloride, oxide, sulfate & (activated B2)) Minerals Chelated; amino acids/Krebs cycle intermediates Niacin (as niacinamide) 20 mg sodium forms Vitamin B6 (as pyridoxine HCl and 38% pyridoxal 5' phosphate 4 mg (activated B6)) Metafolin® is a registered trademark of Merck KGaA, Darmstadt, Germany. Folate (as Metafolin®, L-5-MTHF) 667 mcg DFE (400 mcg L-5-MTHF) Vitamin B12 (as methylcobalamin) 500 mcg Biotin 300 mcg Pantothenic acid (as calcium pantothenate) (B5) 10 mg Choline (as choline bitartrate) 25 mg Iodine (as potassium iodide) 150 mcg Zinc (as zinc citrate) 25 mg Selenium (as selenomethionine) 70 mcg 8 Ask your pharmacist about Pure Encapsulations today or visit PureEncapsulations.com for more information. ‡These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. 9 Drug-Nutrient Depletions Did you know that common drugs have the potential to deplete critical nutrients? Ask your pharmacist how products from Pure Encapsulations can support drug-nutrient depletion. Potential Nutrient ® Drug Category
Recommended publications
  • Methionine Synthase Supports Tumor Tetrahydrofolate Pools

    Methionine Synthase Supports Tumor Tetrahydrofolate Pools

    bioRxiv preprint doi: https://doi.org/10.1101/2020.09.05.284521; this version posted September 7, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Methionine synthase supports tumor tetrahydrofolate pools Joshua Z. Wang1,2,#, Jonathan M. Ghergurovich1,3,#, Lifeng Yang1,2, and Joshua D. Rabinowitz1,2,* 1 Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, New Jersey, USA 2 Department of Chemistry, Princeton University, Princeton, New Jersey, USA 3 Department of Molecular Biology, Princeton University, Princeton, New Jersey, USA # These authors contributed equally to this work. *Corresponding author: Joshua Rabinowitz Department of Chemistry and the Lewis-Sigler Institute for Integrative Genomics, Princeton University, Washington Rd, Princeton, NJ 08544, USA Phone: (609) 258-8985; e-mail: [email protected] Conflict of Interest Disclosure: J.D.R. is a paid advisor and stockholder in Kadmon Pharmaceuticals, L.E.A.F. Pharmaceuticals, and Rafael Pharmaceuticals; a paid consultant of Pfizer; a founder, director, and stockholder of Farber Partners and Serien Therapeutics. JDR and JMG are inventors of patents in the area of folate metabolism held by Princeton University. 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.09.05.284521; this version posted September 7, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Mammalian cells require activated folates to generate nucleotides for growth and division. The most abundant circulating folate species is 5-methyl tetrahydrofolate (5-methyl- THF), which is used to synthesize methionine from homocysteine via the cobalamin-dependent enzyme methionine synthase (MTR).
  • Buffered Mag Glycinate W L-Taurine P.Pub

    Buffered Mag Glycinate W L-Taurine P.Pub

    Magnesium BisGlycinate TM buffered w/L-Taurine 90 Veggie Capsules NPN80026983 Matrix Nutritional Series Cardiac, Neurological & Musculo-Skeletal Support Matrix Nutritionals Series was designed as an eclectic offering for the Physica Energetics line of remedies primarily to assist in the “reactivation of the mesenchyme” (Dr. Reinhold Voll), via the nutritional complement pathways. These pathways are present in every system throughout the body and require balanced attention. In keeping with the principles of BioEnergetic Medicine, the remedies nourish and support these systems without punishing them with overstimulation or imbalancing factors, which, ultimately, is counterproductive. This approach has been carefully and respectfully designed to provide the necessary natural (organic where available), synergistic factors in proper energetic and biochemical ratios, to ensure assistance towards yielding a deep and lasting result. They are not to be confused with replacement therapy nutraceuticals that may seem to help for the moment, until the patient stops taking them or the condition is driven deeper. These remedies honour The Legacy of BioEnergetic Medicine, and are known by both patient and practitioner to be exceptionally effective. In 2006, the World Health Organization reached consensus experience twitches (in the eyelids as well!), cramps, muscle that a majority of the world's population is magnesium tension, muscle soreness, including back aches, neck pain, deficient. Likewise, in 1995, the Gallop Organization conducted a tension headaches and jaw joint (or TMJ) dysfunction. Also, one survey and found that 95% of adult Americans are magnesium may experience chest tightness or a peculiar sensation that one deficient! can't take a deep breath. Sometimes a person may sigh a lot.
  • The Vitamin B12 Coenzyme

    The Vitamin B12 Coenzyme

    THE VITAMIN B12 COENZYME D. DoLPHIN, A. W. JoHNSON, R. RoDRIGO and N. SHAW Department of Chemistry, University of Nottingham, U.K. INTRODUCTION In 19•58 Barker and his associatesl-3 recognized a new coenzyme which controlled the conversion of glutamate into ß-methylaspartate by Clostridium tetanomorpkim. The coenzyme was shown4 to be related to !f;-vitamin B12, i.e. contair ing an adenine nucleotide grouping in place of the 5,6-dimethyl­ benziminawle nucleotide of vitamin B12, although similar coenzymes con­ taining btnziminazole or 5,6-dimethylbenziminazole were produced by growing C. tetanomorphum in the presence of the a ppropriate base5. Other variations of the nucleotide base have been achieved using Propionibacterium arabinosum in the presence of other purines and benziminazoles6• The pres­ ence of;:he coenzymes in a wide variety of micro-organisms such as several species of Actinomycetes including Streptomyces olivaceus and S. griseus has been dem( mstrated by the glutamate isomerase assay7 or by isolation. I t appears thü Vitamin B12 and its analogues are always biosynthesized in the form of their coenzymes. Preliminary physical and chemical studies sug­ gested that in the 5,6-dimethylbenzirninazolyl cobamide coenzyme the cyanide gr )up of vitamin B12, cyanocobalamin, was replaced by an adenine nucleoside':, 5, 8 and the determination9 of the complete structure (I; R = 5'-de·)xyadenosyl) of the coenzyme by X-ray analysis revealed the existence c f an essentially covalent bond between the cobalt atom and the S'.. carbon üom of the additional 5'-deoxyadenosine group. The molecule Me CH 2• CO· NH2 In the vitamin 8 12 coenzyme R =5' - deoxyadenosyl = Me Me 539 D.
  • The Potential Protective Role of Vitamin K in Diabetic Neuropathy

    The Potential Protective Role of Vitamin K in Diabetic Neuropathy

    VITAMINS The potential protective role of vitamin K in diabetic neuropathy DILIP MEHTA Viridis Biopharma 6/10 Jogani Industrial Complex ew cases of diabetes are symptomatic pain relief (3-5). V. N. Purav Marg, Chunabhatti increasing worldwide at a rapid Mumbai 400022, India The etiopathology of peripheral pace, with the total number of neuropathy is poorly understood and many [email protected] people with diabetes was projected factors, including dietary deficiencies, may www.viridisbiopharma.com Nto rise from 171 million in 2000 to 366 million contribute to the clinical manifestation of the in 2030 – an increase of nearly 200 million in condition. Deficiency of vitamin B12 (also only three decades. There are more cases of known as cobalamin), which results in a lack diabetes in women and urban populations, of a related compound, methylcobalamin, is with diabetes in developing countries projected manifested by megaloblastic anemia, and to double in the coming years (1). has been associated with significant Based on reports from the Centers for neurological pathology, especially peripheral Disease Control and Prevention, type 2 neuropathy (6-8). Vitamin B12 is also diabetes dult onset diabetes affects associated with the onset of diabetic approximately 9.3% of the general neuropathy. In patients with diabetic population in the United States in contrast to neuropathy, vitamin B12 deficiency may be 25.9% among those 65 years or older (2). aggravated by the use of antidiabetic agents Diabetes mellitus accounts for 90% of the such as metformin (9-11). Even short-term cases of diabetes patients (3,4). treatment with metformin causes a decrease The prevalence of type 2 diabetes in serum cobalamin, folic acid and an increases with age, higher then 25 body increase in homocysteine, which leads to mass index and the presence of the disease peripheral neuropathy in patients with in family history.
  • Potential Benefits of Methylcobalamin: a Review

    Potential Benefits of Methylcobalamin: a Review

    Open Access Austin Journal of Pharmacology and Therapeutics Review Article Potential Benefits of Methylcobalamin: A Review Gupta JK* and Qureshi Shaiba Sana Department of Pharmacology, GLA University Mathura, Abstract India Methylcobalamin is an active form of vitamin B12 that helps in synthesis *Corresponding author: Jeetendra Kumar Gupta, of methionine and S-adenosylmethionine. It is required for integrity of myelin, Department of Pharmacology, Institute of Pharmaceutical neuronal function, proper red blood cell formation and DNA synthesis. The largest Research, GLA University Mathura, India group of vitamin B12 deficiency is found in typical vegetarians all over the world, which can be alleviated with its analogue Methylcobalamin. It is a beneficial Received: August 17, 2015; Accepted: September 30, drug to most of the common disorders like cardiovascular disorders, diabetes, 2015; Published: October 08, 2015 anemia, hyperhomocysteinemia and degenerative disorders. Methylcobalamin helps in the synthesis of neuronal lipids, regeneration of axonal nerves and has neuroprotective activity, which promote neurons to function in proper way and thus improves Alzheimer disease, Parkinsonism, Dementia and neuropathic syndromes. It is an approved treatment for peripheral neuropathy. Keywords: Mecobalamin; Neuropathy; Anemia; Nootropic; Dietary supplement Abbreviations essential for cell growth and replication. Sometimes the liver cannot convert cyanocobalamin into adequate amount of methylcobalamin SAMe: S-Adenosyl Methionine; ERK: Extracellular Signal- needed for proper neuronal functioning. Through enhanced Regulated Kinases; PKB: Protein Kinase B; B-globulin: Beta Globulin; methylation, it exerts its nerve cell protective effect and accelerates ENFD: Epidermal Nerve Fiber Density; DPN: Diabetic Peripheral its growth. A lot of energy is required for cyanocobalamin to remove Neuropathy; NSAIDs: Non Steroidal Anti Inflammatory Drugs; THF: its cyanide and replaces it with methyl group [3].
  • Vitamin and Mineral Requirements in Human Nutrition

    Vitamin and Mineral Requirements in Human Nutrition

    P000i-00xx 3/12/05 8:54 PM Page i Vitamin and mineral requirements in human nutrition Second edition VITPR 3/12/05 16:50 Page ii WHO Library Cataloguing-in-Publication Data Joint FAO/WHO Expert Consultation on Human Vitamin and Mineral Requirements (1998 : Bangkok, Thailand). Vitamin and mineral requirements in human nutrition : report of a joint FAO/WHO expert consultation, Bangkok, Thailand, 21–30 September 1998. 1.Vitamins — standards 2.Micronutrients — standards 3.Trace elements — standards 4.Deficiency diseases — diet therapy 5.Nutritional requirements I.Title. ISBN 92 4 154612 3 (LC/NLM Classification: QU 145) © World Health Organization and Food and Agriculture Organization of the United Nations 2004 All rights reserved. Publications of the World Health Organization can be obtained from Market- ing and Dissemination, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permis- sion to reproduce or translate WHO publications — whether for sale or for noncommercial distri- bution — should be addressed to Publications, at the above address (fax: +41 22 791 4806; e-mail: [email protected]), or to Chief, Publishing and Multimedia Service, Information Division, Food and Agriculture Organization of the United Nations, 00100 Rome, Italy. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization and the Food and Agriculture Organization of the United Nations concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.
  • The Efficacy and Safety of Intramuscular Injections Of

    The Efficacy and Safety of Intramuscular Injections Of

    Original Article Singapore Med J 2011; 52(12) : 868 The efficacy and safety of intramuscular injections of methylcobalamin in patients with chronic nonspecific low back pain: a randomised controlled trial Chiu C K, Low T H, Tey Y S, Singh V A, Shong H K ABSTRACT both singly or in combination with other forms Introduction:Chronic, nonspecific low back of treatment. pain is a difficult ailment to treat and poses an economic burden in terms of medical Keywords: methylcobalamin, nonspecific low expenses and productivity loss. The aim of back pain, vitamin B12 this study was to determine the efficacy and Singapore Med J 2011; 52(12): 868-873 safety of intramuscular metylcobalamin in the treatment of chronic nonspecific low back INTRODUCTION pain. Low back pain (LBP) affects a substantial proportion of the population. Almost every person will encounter an Methods: This was a double-blinded, episode of back pain at some point in one’s life. Back randomised, controlled experimental study. pain does not discriminate based on gender, age, race or 60 patients were assigned to either the culture. It disables the working adult from performing his methylcobalamin group or the placebo group. duties and paralyses the society due to the cost incurred The former received intramuscular injections in terms of treatment and productivity loss. In 1988, a of 500 mcg parenteral methylcobalamin in 1 survey was conducted in a semirural area in Malaysia. Department of ml solution three times a week for two weeks, Orthopaedic A total of 2,594 individuals from a multi-racial (Malay, Surgery, and the placebo group received 1 ml normal Chinese, Indian) community were interviewed.
  • Cyanocobalamin-A Case for Withdrawal

    Cyanocobalamin-A Case for Withdrawal

    686 Journal of the Royal Society of Medicine Volume 85 November 1992 Cyanocobalamin- a case for withdrawal: discussion paper A G Freeman MD FRCP Meadow Rise, 3 Lakeside, Swindon SN3 IQE Keywords: anaemia, pernicious; optic neuropathies; chronic cyanide intoxication; hydroxocobalamin; cyanocobalamin It seems evident that controversy still surrounds the reduced ability to detoxify the cyanide in the tobacco- treatment of pernicious anaemia and other vitamin smoke to which they are exposed'0. B12 deficiency disorders. The long quest for the 'anti- Patients with tobacco amblyopia who have normal pernicious anaemia factor' in the liver seemed to serum vitamin B12 levels need not continue therapy have ended in 1948 when pure cyanocobalamin was with intramuscular hydroxocobalamin once their isolated. This was found to be very active thera- visual acuity and visual fields have returned to peutically when given by intramuscular injection and normal providing they abstain from further smoking. was non-toxic in extremely high doses'. However, those patients who have low serum vitamin Lederle, in a recent commentary2, advocates that B12 levels or evidence of -defective vitamin B12 patients with pernicious anaemia should now be absorption will need to continue-indefinitely with treated with oral cyanocobalamin. He is not without hydroxocobalamin irrespective of their smoking support in that 40% of patients with pernicious habits as will all patients with pernicious anaemia anaemia in Sweden are being similarly treated3. and other vitamin B12 deficiency disorders who are He further states that such!- treatment is cheap at risk of developing- optic neuropathy if they and effective, produces clinical and haematological are smokers.
  • DRIDIETARY REFERENCE INTAKES Thiamin, Riboflavin, Niacin, Vitamin

    DRIDIETARY REFERENCE INTAKES Thiamin, Riboflavin, Niacin, Vitamin

    Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline http://www.nap.edu/catalog/6015.html DIETARY REFERENCE INTAKES DRI FOR Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline A Report of the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline and Subcommittee on Upper Reference Levels of Nutrients Food and Nutrition Board Institute of Medicine NATIONAL ACADEMY PRESS Washington, D.C. Copyright © National Academy of Sciences. All rights reserved. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline http://www.nap.edu/catalog/6015.html NATIONAL ACADEMY PRESS • 2101 Constitution Avenue, N.W. • Washington, DC 20418 NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance. This project was funded by the U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion, Contract No. 282-96-0033, T01; the National Institutes of Health Office of Nutrition Supplements, Contract No. N01-OD-4-2139, T024, the Centers for Disease Control and Prevention, National Center for Chronic Disease Preven- tion and Health Promotion, Division of Nutrition and Physical Activity; Health Canada; the Institute of Medicine; and the Dietary Reference Intakes Corporate Donors’ Fund.
  • Biotin Fact Sheet for Consumers

    Biotin Fact Sheet for Consumers

    Biotin Fact Sheet for Consumers What is biotin and what does it do? Biotin is a B-vitamin found in many foods. Biotin helps turn the carbohydrates, fats, and proteins in the food you eat into the energy you need. How much biotin do I need? The amount of biotin you need each day depends on your age. Average daily recommended amounts are listed below in micrograms (mcg). Life Stage Recommended Amount Birth to 6 months 5 mcg Infants 7–12 months 6 mcg Children 1–3 years 8 mcg Children 4–8 years 12 mcg Biotin is naturally present in some Children 9–13 years 20 mcg foods, such as salmon and eggs. Teens 14–18 years 25 mcg Adults 19+ years 30 mcg Pregnant teens and women 30 mcg Breastfeeding teens and women 35 mcg What foods provide biotin? Many foods contain some biotin. You can get recommended amounts of biotin by eating a variety of foods, including the following: • Meat, fish, eggs, and organ meats (such as liver) • Seeds and nuts • Certain vegetables (such as sweet potatoes, spinach, and broccoli) What kinds of biotin dietary supplements are available? Biotin is found in some multivitamin/multimineral supplements, in B-complex supplements, and in supplements containing only biotin. Am I getting enough biotin? Most people get enough biotin from the foods they eat. However, certain groups of people are more likely than others to have trouble getting enough biotin: • People with a rare genetic disorder called “biotinidase deficiency” • People with alcohol dependence • Pregnant and breastfeeding women 2 • BIOTIN FACT SHEET FOR CONSUMERS What happens if I don’t get enough biotin? Biotin and healthful eating Biotin deficiency is very rare in the United States.
  • COMPARISON of the WHO ATC CLASSIFICATION & Ephmra/Intellus Worldwide ANATOMICAL CLASSIFICATION

    COMPARISON of the WHO ATC CLASSIFICATION & Ephmra/Intellus Worldwide ANATOMICAL CLASSIFICATION

    COMPARISON OF THE WHO ATC CLASSIFICATION & EphMRA/Intellus Worldwide ANATOMICAL CLASSIFICATION: VERSION June 2019 2 Comparison of the WHO ATC Classification and EphMRA / Intellus Worldwide Anatomical Classification The following booklet is designed to improve the understanding of the two classification systems. The development of the two systems had previously taken place separately. EphMRA and WHO are now working together to ensure that there is a convergence of the 2 systems rather than a divergence. In order to better understand the two classification systems, we should pay attention to the way in which substances/products are classified. WHO mainly classifies substances according to the therapeutic or pharmaceutical aspects and in one class only (particular formulations or strengths can be given separate codes, e.g. clonidine in C02A as antihypertensive agent, N02C as anti-migraine product and S01E as ophthalmic product). EphMRA classifies products, mainly according to their indications and use. Therefore, it is possible to find the same compound in several classes, depending on the product, e.g., NAPROXEN tablets can be classified in M1A (antirheumatic), N2B (analgesic) and G2C if indicated for gynaecological conditions only. The purposes of classification are also different: The main purpose of the WHO classification is for international drug utilisation research and for adverse drug reaction monitoring. This classification is recommended by the WHO for use in international drug utilisation research. The EphMRA/Intellus Worldwide classification has a primary objective to satisfy the marketing needs of the pharmaceutical companies. Therefore, a direct comparison is sometimes difficult due to the different nature and purpose of the two systems.
  • The Vitamin B Complex and Ascorbic Acid

    The Vitamin B Complex and Ascorbic Acid

    C H A P T E R 63 The Vitamin B Complex and Ascorbic Acid Robert Marcus and Ann M. Coulston This chapter provides a summary of physiological and therapeutic roles of members of the vitamin B complex and of vitamin C. The vitamin B complex comprises a large number of compounds that differ extensively in chemical structure and biological action. They were grouped in a single class because they originally were isolated from the same sources, notably liver and yeast. There are traditionally eleven members of the vitamin B complex— namely, thiamine, riboflavin, nicotinic acid, pyridoxine, pantothenic acid, biotin, folic acid, cyanocobalamin, choline, inositol, and paraaminobenzoic acid. Paraaminobenzoic acid is not considered in this chapter, as it is not a true vitamin for any mammalian species but is a growth factor for certain bacteria, where it is a precursor for folic acid synthesis. Although not a traditional member of the group, carnitine also is considered in this chapter because of its biosynthetic relationship to choline and the recent recognition of deficiency states. Folic acid and cyanocobalamin are considered in Chapter 54 because of their special function in hematopoiesis. Vitamin C is especially concentrated in citrus fruits and thus is obtained mostly from sources differing from those of members of the vitamin B complex. CHAPTER 63 WATER-SOLUBLE VITAMINS: THE VITAMIN B COMPLEX AND ASCORBIC ACID 1767 II. ASCORBIC ACID (VITAMIN C) History. Scurvy, the deficiency disease caused by lack of vi- tamin C, has been known since the time of the Crusades, es- pecially among northern European populations who subsisted on diets lacking fresh fruits and vegetables over extensive pe- riods of the year.